We further demonstrate that in individuals of European descent, the CASR variant at rs1801725, but not rs1801726, are associated with calcium and bone-related secondary cancer phenotypes, a higher risk of developing secondary neoplastic lesions in the lungs and bone, and interestingly, deficiency of humoral immunity. Here, CASR is linked to cancer.